Triomicsa startup building an AI-powered platform to help oncologists and administrative staff automate data-heavy tasks like clinical trial matching and appointment preparation has raised $22 million in Series B funding.
The round was led by Battery Ventures, with participation from backers Nexus Venture Partners, Lightspeed, Y Combinator and others.
The good news is that oncology breakthroughs are keeping patients alive longer. This welcome trend, however, creates dense, multi-year medical files that take a long time to be reviewed and deciphered by healthcare personnel.
A typical medical chart includes physician progress notes, imaging and pathology reports, and even fax scans. “We saw medical records [with] thousands of pages of information,” Triomics co-founder Sarim Khan told TechCrunch.
Founded in 2021, the startup raised $15 million in Series A in mid-2024. Initially focused on helping physicians identify the most appropriate clinical trials for their patients, Triomics expanded its platform as LLM capabilities grew. Over the past two years, Triomics has added verifiable patient summaries to its platform, displaying key information directly within the tools clinicians already use, without requiring them to switch applications.
By reducing appointment preparation time, these summaries give oncologists more time with their patients. The efficiency gain matters beyond individual appointments: in oncology, where patient histories are unusually complex and staff burnout is a persistent problem, tools that reduce administrative burden have a huge impact.
Triomics is also being used to automate the tedious task of reporting tumors to state registries, a legal mandate for cancer centers.
While general AI agents excel at basic summaries, prominent institutions like Memorial Sloan Kettering (MSK) and Yale Cancer Center use Triomics because its models are specifically trained on oncology data, Khan explained.
The most direct competition to Triomics comes from AI doctors like Microsoft’s Abridge and Nuance — tools that use artificial intelligence to listen to and document patient-doctor conversations — when it comes to summarizing patient charts.
Despite tough competition, Triomics is growing rapidly. According to Khan, the startup has grown its enterprise customer base fourfold in the past year, leading to a 10x increase in annual recurring revenue.
Pictured left to right: Sarim Khan, Co-Founder and CEO of Triomicsand Hrithuraj SinghTriomics co-founder and CTO.
When you purchase through links in our articles, we may earn a small commission. This does not affect our editorial independence.
